Nisa Investment Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Nisa Investment Advisors's IRMD Position: Q1 2026 in Review
Nisa Investment Advisors held its iRadimed (IRMD) position steady in Q1 2026 at 77 shares worth $7.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.
Nisa Investment Advisors first reported a position in IRMD in Q3 2020 and has held it in 23 quarters since. The position peaked at $208K in Q4 2020. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Nisa Investment Advisors held 77 shares of iRadimed worth $7.41K as of Q1 2026.
- Nisa Investment Advisors left its iRadimed share count unchanged in Q1 2026.
- iRadimed made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2342 holding.
- Nisa Investment Advisors first reported a position in iRadimed in Q3 2020 and has held it in 23 quarters since.
- Nisa Investment Advisors's iRadimed position peaked at $208K in Q4 2020.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.